Cargando…
Testosterone therapy with Testopel® and the Esoterix Laboratory assay: A CASE study
We present a patient receiving Testopel® implants whose serum testosterone levels, as measured by a CDC certified assay, were accurately predicted by a multi-compartmental model. This is the first time a model has predicted measured serum testosterone levels within 4% of values calculated. To our kn...
Autores principales: | Seitman, David, Fallon, Joseph, Kimmels, Barry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8165545/ https://www.ncbi.nlm.nih.gov/pubmed/34094874 http://dx.doi.org/10.1016/j.eucr.2021.101714 |
Ejemplares similares
-
Testosterone Pellet Associated Dermatitis: Report and Review of Testopel-related Cutaneous Adverse Effects
por: Heldt Manica, Lucas A, et al.
Publicado: (2017) -
A large staghorn stone diagnosed and managed in an asymptomatic patient using the “Kidney Injury Test (Kit)” spot urine assay: A case report
por: Charondo, Leslie Bernal, et al.
Publicado: (2021) -
Ipsilateral robot assisted laparoscopic side to side ureteroureterostomy in a duplex collecting system – A video case report with 1 year follow up
por: Haroon, Usman M., et al.
Publicado: (2020) -
Unexpected encapsulated hematoma after Rezum therapy: First outcome of an emerging therapy
por: Alkeraithe, Fawaz, et al.
Publicado: (2022) -
Irrigation fluid absorption syndrome during HoLEP: A case study
por: Slots, Charlotte, et al.
Publicado: (2022)